About this trial
The purpose of this study is to to explore the safety and efficacy of the EXOPULSE Mollii suit, a full-body electrostimulation suit, for individuals with neurological or neuromuscular conditions that cause spasticity, hyperreflexia, and/or pain.
Eligibility criteria
Qualifiers
Age 18 to 75 years old
Medical clearance from physician
Individuals who experience spasticity, pain, or hyperreflexia due to neurological or neuromuscular conditions or individuals with a diagnosis of Multiple Sclerosis or Fibromyalgia
having a definite diagnosis for at least one month
Disqualifiers
Implanted medical devices or equipment which can be disrupted by magnets (ex. Shunts)
Swollen, infected, or inflamed areas or skin eruptions (e.g., phlebitis, thrombophlebitis, varicose veins, etc.) in areas where the suit will be used
No established somatic or neuropsychiatric diagnosis prior to enrollment in the study
Pregnant and/or nursing
Trial design
Treatments tested in this trial
- Active full-body stimulation
- Sham full-body stimulation
Treatment groups
Sponsors and collaborators
Shirley Ryan AbilityLab
Lead sponsor
Otto Bock Healthcare Products GmbH
Collaborator